Skip to main content
Livermore
Livermore
ZHEN

Myriad Genetics Inc

MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000899923

No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.

Holders of 5% or more of MYGN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Myriad Genetics Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of MYGN
HolderLatest formStakeChangeFirst filedLatest filingFiling
BlackRock Portfolio Management LLC13G10.40%9.90M sharesNewSep 4, 20261 filingSep 4, 2026SEC
BlackRock, Inc.13G/A8.50%7.98M shares−6.80 ppfrom 15.30%Jul 17, 20252 filingsApr 7, 2026SEC
Integrated Core Strategies (US) LLC13G/A7.20%6.70M shares+2.10 ppfrom 5.10%Aug 4, 20253 filingsFeb 11, 2026SEC
Vestal Point Capital, LP13G6.10%5.74M sharesNewAug 14, 20261 filingAug 14, 2026SEC
State Street Corp13G5.30%4.99M shares+0.60 ppfrom 4.70%Feb 16, 20216 filingsAug 7, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

43 Schedule 13D and 13G filings on Myriad Genetics Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on MYGN
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 4, 202612:57 PM ETBlackRock Portfolio Management LLC13G10.40%9.90M sharesNewAug 31, 2026SEC
Aug 14, 20264:59 PM ETGlenview Capital Management, LLCand 1 other13G/A0.00%0 shares−5.30 ppfrom 5.30%Below 5%Jun 30, 2026SEC
Aug 14, 20264:09 PM ETVestal Point Capital, LPand 1 other13G6.10%5.74M sharesNewJun 30, 2026SEC
Aug 7, 202610:09 AM ETState Street Corp13G5.30%4.99M shares+0.60 ppfrom 4.70%Jun 30, 2026SEC
May 12, 202611:38 AM ETState Street Corp13G4.70%4.42M shares−1.70 ppfrom 6.40%Below 5%Mar 31, 2026SEC
Apr 7, 202612:39 PM ETBlackRock, Inc.13G/A8.50%7.98M shares−6.80 ppfrom 15.30%Mar 31, 2026SEC
Mar 27, 202610:49 AM ETVanguard Group Inc13G/A0.00%0 shares−8.47 ppfrom 8.47%Below 5%Mar 13, 2026SEC
Feb 11, 20265:20 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A7.20%6.70M shares+2.10 ppfrom 5.10%Dec 31, 2025SEC
Feb 9, 20267:54 AM ETState Street Corp13G6.40%5.97M shares–Dec 31, 2025SEC
Jan 13, 20264:39 PM ETGlenview Capital Management, LLCand 1 other13G5.30%4.94M shares–Jan 6, 2026SEC
Nov 12, 20254:10 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A5.10%4.75M shares−0.20 ppfrom 5.30%Sep 30, 2025SEC
Nov 12, 20253:35 PM ETBarclays PLC13G/A4.23%3.94M shares−1.08 ppfrom 5.31%Below 5%Sep 30, 2025SEC
Oct 31, 202511:05 AM ETVanguard Group Inc13G/A8.47%7.88M shares−1.57 ppfrom 10.04%Sep 30, 2025SEC
Aug 14, 20257:38 PM ETDisciplined Growth Investors Inc13G/A0.80%754.0K shares−4.30 ppfrom 5.10%Below 5%Jun 30, 2025SEC
Aug 12, 20254:06 PM ETBarclays PLC13G5.31%4.90M sharesNewJun 30, 2025SEC
Aug 12, 202510:34 AM ETWellington Management Group LLPand 2 others13G/A0.00%0 shares−5.00 ppfrom 5.00%Below 5%Jun 30, 2025SEC
Aug 4, 20254:05 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A5.30%4.92M shares–Jun 30, 2025SEC
Jul 29, 20251:54 PM ETVanguard Group Inc13G/A10.04%9.26M shares–Jun 30, 2025SEC
Jul 17, 20257:54 PM ETBlackRock, Inc.13G/A15.30%14.1M shares–Jun 30, 2025SEC
May 15, 20254:36 PM ETDisciplined Growth Investors Inc13G5.10%4.29M sharesNewMar 31, 2025SEC
May 12, 202510:44 AM ETWellington Management Group LLPand 2 others13G/A5.00%4.59M shares−1.60 ppfrom 6.60%Mar 31, 2025SEC
Feb 14, 20258:32 AM ETCamber Capital Management LPand 1 other13G/A3.41%3.10M shares–Below 5%Dec 31, 2024SEC
Feb 10, 202510:25 AM ETWellington Management Group LLPand 3 others13G/A6.60%6.00M shares–Dec 31, 2024SEC
Mar 1, 2023Glenview Capital Management, LLC13GOld format–New–SEC
Feb 14, 2023Camber Capital Management LP13G/AOld format–––SEC
Feb 9, 2023Vanguard Group Inc13G/AOld format–––SEC
Feb 6, 2023Wellington Management Group LLP13G/AOld format–––SEC
Jan 31, 2023State Street Corp13G/AOld format–––SEC
Jan 9, 2023Earnest Partners LLC13G/AOld format–––SEC
May 12, 2022Camber Capital Management LP13GOld format–––SEC
Feb 14, 2022Camber Capital Management LP13G/AOld format–––SEC
Feb 11, 2022Earnest Partners LLC13G/AOld format–––SEC
Feb 11, 2022State Street Corp13G/AOld format–––SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 4, 2022Wellington Management Group LLP13GOld format–New–SEC
Jan 27, 20221:59 PM ETBlackRock Inc.13G/AOld format–––SEC
Jan 25, 20226:45 PM ETBlackRock Inc.13GOld format–––SEC
Feb 16, 2021Camber Capital Management LP13G/AOld format–––SEC
Feb 16, 2021D. E. Shaw & Co, L.P.13G/AOld format–––SEC
Feb 16, 2021Earnest Partners LLC13GOld format–New–SEC
Feb 16, 2021State Street Corp13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13G/AOld format–––SEC
Jan 25, 20214:49 PM ETBlackRock Inc.13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Myriad Genetics Inc shares.

No Form 144 notices for Myriad Genetics Inc are on file.